Bone Tumors

LINKS

M.D. Anderson Cancer Center: Bone cancer  

M.D. Anderson Cancer Center: Osteosarcoma

Memorial Sloan-Kettering Cancer Center: Bone cancer    

LITERATURE SELECTION

Colze G et al.: "Imaging of Highly Malignant Osteosarcoma with Iodine-123-Vascular Endothelial Growth Factor", Oncology. 2012 Jun 21;83(1):45-49. [Epub ahead of print]

Hernberg MM et al.: “Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma”, Med Oncol. 2010 Jun 17. [Epub ahead of print]

Eyre R et al.: “The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 – 2002”, BMC Cancer. 2010 Jul 6;10(1):357. [Epub ahead of print]

Song WS et al.: “Prognosis of extremity osteosarcoma in patients aged 40-60 years: a cohort/case controlled study at a single institute”, Eur J Surg Oncol. 2010 May;36(5):483-8

Lee B et al.: "The efficacy of percutaneous vertebroplasty for vertebral metastases associated with solid malignancies", 2009 Jun;45(9):1597-1602

Sande TA et al.: "Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: Results from a randomised multicentre trial", Radiother Oncol 2009 May; 91(2):261-66

CLINICAL GUIDELINES

Osteosarcoma – Mifamurtide for osteosarcoma – National Institute for Health and Clinical excellence(nice), UK, www.nice.org.uk

NEWS  

Bone cancer and symptoms

Bone cancer and symptoms – European Journal of Cancer

Osteosarcoma and tumor size

 Osteosarcoma and tumor size -  Pediatric Blood & Cancer

Oral ibandronate and  bone metastasis

Ibandronate and  bone metastasis – Journal of Clinical Oncology

EDITORIALS

Prognostic value of Alkaline Phosphatase in Adults with Localised Osteosarcoma - Jos Bramer

Non-metastatic osteosarcoma and high-dose chemotherapy with autologous peripheral blood stem cell support - Fikret Arpaci

 Risks associated with opioid use at the end of life - Russel Portenoy

Owner and Editor-in-Chief Gianpaolo Andreoletti, Oncologist and Science Journalist P.IVA. 01823870165

PRIVACY AND LEGAL DISCLAIMER